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Summary
Breast cancer is the most common cancer in the female population. In Croatia, breast cancer makes up to 26% of all 
newly diagnosed cases of cancer in females. Breast cancer primarily metastasizes to bones, lungs, liver, brain and lymph 
nodes. We report a case of isolated metastasis of breast cancer to mandible in a 76-year-old female patient, who was diag-
nosed with cancer eleven years ago, which presented with diffi  cult chewing, discrete pain, and continuing increase in tumor 
marker Ca15-3. Pathohistology of intraoral biopsy confi rmed a breast cancer metastasis. The patient received with palliative 
radiotherapy and hormone therapy. Every oncological patient complaining about the disorders in the mandibular area must 
be subject to thorough examination and metastasis should be included in the diff erential diagnosis. Metastatic lesion in the 
mandible is a sign of disseminated disease, and the treatment is most often palliative.
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RIJETKI SLUČAJ METASTAZE KARCINOMA DOJKE U MANDIBULI – PRIKAZ SLUČAJA
Sažetak
Karcinom dojke je najčešća maligna bolest u ženskoj populaciji. U Hrvatskoj, karcinom dojke čini oko 26% svih novo-
dijagnosticiranih karcinoma u žena. Karcinom dojke najčešće metastazira u kosti, pluća, jetru, mozak te limfne čvorove. U 
ovom radu prikazujemo slučaj izoliranog metastatskog karcinoma dojke u mandibuli kod 76 godišnje pacijentice, kojoj je 
karcinom dojke bio dignosticiran prije 11 godina. Pacijentica se prezentirala sa otežanim žvakanjem, diskretnom boli, te 
povišenjem tumorskog biljega Ca15-3. Metastaza je dokazana intraoralnom biopsijom. Pacijentica je liječena palijativnom 
radioterapijom i hormonskom terapijom. Svaki onkološki pacijent sa simptomima u području mandibule se mora detaljno 
obraditi, te se treba posumnjati i na mogući sekundarizam. Metastatski karcinom mandibule je znak diseminirane bolesti te 
je shodno tome liječenje najčešće palijativno.
KLJUČNE RIJEČI: karcinom dojke, metastaza, palijativna radioterapija
INTRODUCTION
Breast cancer is the mos t common cancer 
among women worldwide and the second leading 
cause of death from cancer in women after lung 
cancer. The most common sites of metastases are 
lymph nodes, bones, lungs, liver, and brain(1). Ac-
cording to the Croatian National Cancer Registry, 
there were 2748 newly diagnosed cases of breast 
cancer in Croatian in 2015 which is 26% of all new-
ly diagnosed cases of cancer in woman in Croa-
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tia(2). The primary feature of cancer is its ability to 
invade tissues and metastasize. Metastasizing is a 
complex process in which tumor cell fi rst must de-
tach from the primary tumor, then invade blood 
or lymphatic vessels and survive in circulation. In 
microvasculature tumor cell extravasate through 
the vessel wall and invade the target organ. In or-
der to successfully establish secondary tumor, 
cancer cells must be capable of proliferation and 
evasion of the immune system. Micrometastasis 
can grow up to 2-3 mm in size. For micrometasta-
sis to grow beyond that size, a cancer cell must 
induce the formation of new blood cell for the ad-
equate supply of oxygen and nutrients (3).
PATIENT REPORT
A 76-year-old female patient was diagnosed 
with left-sided breast cancer and treated with 
breast-conserving surgery and axillary dissection 
in 2007. Histopathology revealed invasive lobular 
carcinoma gradus II; tumor size was 3.8 cm, estro-
gen receptor 100% positive, progesterone receptor 
50% positive, Her-2 negative and two of 16 axil-
lary lymph nodes were cancerous. The patient re-
ceived adjuvant chemotherapy: six cycles of adju-
vant chemotherapy with AC regimen (Doxorubi-
cin/Cyclophosphamide) between January and 
May 2008. Followed by the adjuvant radiation 
therapy in TD 50Gy in 25 fractions to the whole 
breast with the photon energy of 6 MV and to the 
supraclavicular and infraclavicular region with a 
combination of photons energy 6 MV and 15MeV 
electrons. Finally, the patient took endocrine ther-
apy (anastrozole 1mg daily) for fi ve years until 
2013.
Regular annual follow up showed a continu-
ing increase in tumor markers Ca15-3 in 2018. Af-
terward, the PET/CT showed pathologic accumula-
tion of FDG (fl uorodeoxyglucose) in the almost 
entire mandible (SUV max 12.5), with no other 
signs of active malignant disease. The patient had 
multiple teeth extraction a few months earlier, and 
we decided to ask for additional radiological. Com-
puted tomography (CT) fi ndings showed tumor 
mass in the corpus of the mandible with multiple 
Figure 1. DRR (Digitally reconstructed radiography).
Figure 2. Photon fi elds in transversal, frontal 
and sagitt al planes.
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areas of the cortical bone defect. Her complaints 
were discrete pain, mild swelling in the mandibu-
lar area and painful chewing. We indicated an in-
traoral biopsy and histopathology confi rmed me-
tastasis of breast cancer. Tumor tissue was estrogen 
receptor 100 % positive, progesterone receptor 80% 
positive, Her-2 negative, Ki-67 23%.
In June 2018, the patient received palliative 
radiation therapy of the mandible through two lat-
erolateral fi elds with a photon energy of 6MV. To-
tal radiation dose was 39Gy in 13 fractions using 
VSIM technique (Figures 1-3). After radiation ther-
apy, the patient started with tamoxifen hormone 
therapy. Two months after radiation and tamoxi-
fen treatment, tumor marker CA 15-3 decreased 
from 38.5 U/ml to 28.2 U/ml. Unfortunately, the 
patient had severe side eff ects of tamoxifen like hot 
fl ashes, fatigue, nausea and growing pain in the 
mandible. Given the stage and biology of the dis-
ease and side eff ects of tamoxifen, we discontin-
ued the therapy. The patient started with chemo-
therapy regimen ribociclib plus exemestane and 
bisphosphonate treatment with ibandronic acid. 
After the fi rst chemotherapy cycle, the patient felt 
bett er, with reduced pain in the mandible.
DISCUSSION
The metastatic tumors of the mandible are 
rare, especially the isolated ones. The metastatic 
malignant tumors of the oral cavity make only 1% 
of newly diagnosed malignant tumors of the oral 
cavity (4). Metastases are most often from breast 
cancer, prostate cancer, lung cancer, and colorec-
tal cancer. Hirshberg analyzed 390 cases of meta-
static tumors to the mandible. The most common 
site was breast (21.8%), followed by lung, adrenal, 
kidney, colorectal, and prostate. There was a gen-
der diff erence with regards to primary site: for 
women, it was breast tumor, followed by adrenal, 
colorectal, female genital organs, and thyroid 
gland tumor; for men, it was lung cancer, followed 
by the prostate, kidney and bone tumor (5).
Diagnosing a metastasis in the mandible can 
be challenging due to the lack of pathognomonic 
signs and symptoms. The common symptoms are 
the pain, progressing swelling, numbness of lower 
lip and chin, intraoral mass, loose or extruded 
teeth, cortical expansion, ulceration, halitosis, tris-
mus and periodontal abscess (6). The diff erential 
diagnosis includes osteomyelitis, bone abscess, 
primary bone tumor, granuloma, multiple myelo-
ma, lymphoma, acute leukemia, sarcoidosis, mul-
tiple sclerosis, sickle cell disease, Lyme disease, 
temporal arteritis (7). The radiological imaging 
analysis of the metastatic process of the mandible 
showed both osteolytic(86%) and osteoblas-
tic(17%) lesions, and in approximately 5% of the 
cases, radiographs were negative (8). The lesion 
biopsy is mandatory especially if the patient has a 
history of malignant disease (9). Treatment of 
metastatic disease of the mandible is primary pal-
liative and include radiotherapy, chemotherapy, 
hormone therapy and rarely surgery. Surgical 
treatment is only considered in the case of solitary 
metastasis. In this case, a multidisciplinary team 
opted for systemic hormone therapy and bisphos-
phonate therapy postpone the progression of dis-
ease (10). Eventually, the treatment should focus 
on pain relief and preservation of oral function. It 
Figure 3. 3-D rendered CT image and position of the linear accelerator.
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is essential to prevent bleeding, infections, frac-
ture, and cachexia (11).
CONCLUSION
We should evaluate every oncological pa-
tient’s complaint about the disorders in a diff erent 
part of the body than expected for a specifi c tumor 
type metastasis should. For solitary lesion of the 
mandible imaging methods such as CT, MRI, PET 
are recommended, followed by a biopsy. All in-
fl ammatory or reactive lesions in the lower jaw, in 
patient with malignant disease history are possi-
ble metastasis. The metastatic lesion of the man-
dible denotes disseminated disease, therefore the 
treatment is palliative.
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